PharmaShots | Incisive News in 3 Shots

Subscribe Now

ANVISA

Celltrion's Regdanvimab (CT-P59) Receives the ANVISA's EUA for the Treatment of COVID-19 in Brazil

Celltrion's Regdanvimab (CT-P59) Receives the ANVISA's EUA for the Treatment of COVID-19 in Brazil

August 13, 2021

Sorrento to Initiate P-II Study of STI-5656 (abivertinib maleate) for COVID-19 in Brazil

Sorrento to Initiate P-II Study of STI-5656 (abivertinib maleate) for COVID-19 in Brazil

October 15, 2020

AbbVie's Rinvoq (upadacitinib) Receives ANVISA's Approval for Rheumatoid Arthritis

AbbVie's Rinvoq (upadacitinib) Receives ANVISA's Approval for Rheumatoid Arthritis

February 5, 2020

Celltrion's Herzuma (trastuzumab- biosimilar) Receives ANVISA's Approval for Breast and Gastric Cancer in Brazil

Celltrion's Herzuma (trastuzumab- biosimilar) Receives ANVISA's Approval for Breast and Gastric Cancer in Brazil

May 24, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us